ACET — Adicet Bio, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1720580 ·
Last close
$8.33
Market Cap
$77.87M
52W High
$8.90
52W Low
$6.01
ADV30
122,868
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -21,570,000 | -20,244,000 | 169,382,000 | 36,245,000 | 29,317,000 |
| Dec 2025 | 0 | — | -31,886,000 | -30,516,000 | 192,355,000 | 38,918,000 | 33,145,000 |
| Sep 2025 | 0 | — | -27,952,000 | -26,856,000 | 140,479,000 | 29,099,000 | 31,337,000 |
| Jun 2025 | 0 | — | -32,392,000 | -31,217,000 | 162,972,000 | 34,720,000 | 29,600,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-95,246,000
Investing CF
$2,393,000
Financing CF
$75,245,000
CapEx
$-1,924,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-17.98
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-614,697,000
Inventory
—
Receivables
$342,000
ST Investments
$119,612,000
EBIT TTM
$-116,767,000
Pretax Income TTM
$-116,803,000
Interest Exp TTM
$36,000
Analysts
6
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -122,114,000 | -116,803,000 | 192,355,000 | 33,145,000 | — | -95,246,000 |
| Dec 2024 | 0 | -127,615,000 | -117,122,000 | 220,219,000 | 33,610,000 | — | -92,378,000 |
| Dec 2023 | 0 | -132,576,000 | -142,658,000 | 207,295,000 | 37,120,000 | — | -93,717,000 |
| Dec 2022 | 24,990,000 | -72,551,000 | -69,790,000 | 330,690,000 | 38,352,000 | — | -44,765,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-4.19
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $8.33 · call volume: 310 · put volume: 21
Expected Move to 2026-07-17:
±$3.83
(45.98%) —
implied range
$4.50 –
$12.16
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RLYB | Rallybio Corp | $77.88M | $14.70 | — |
| OSTX | OS Therapies Inc | $77.94M | $1.75 | — |
| GANX | Gain Therapeutics, Inc. | $77.63M | $1.82 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | $76.78M | $1.24 | — |
| HYFT | MindWalk Holdings Corp. | $76.14M | $1.63 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
2026-05-25 13:55 · Yahoo
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
2026-05-14 20:00 · Yahoo
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-05-13 20:01 · Yahoo
Adicet Bio (ACET) Upgraded to Buy: Here's Why
2026-03-24 16:00 · Yahoo
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
2026-03-12 20:00 · Yahoo
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
2026-01-30 12:00 · Yahoo
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
2026-01-07 12:00 · Yahoo
Adicet Bio Announces Reverse Stock Split
2025-12-26 13:30 · Yahoo
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
2025-11-28 19:23 · Yahoo
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
2025-11-12 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.